A Novel Antibody-Drug Conjugate (ADC) Delivering a DNA Mono-Alkylating Payload to Chondroitin Sulfate Proteoglycan (CSPG4)-Expressing Melanoma
Ricarda M. Hoffmann(Guy's Hospital), Sophia N. Karagiannis(King's College London)
Cited by 38
Related Papers
Targeting folate receptor alpha for cancer treatment
|Oncotarget|2016|447
Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth
|Clinical Cancer Research|2024|27
Functionally Active Fc Mutant Antibodies Recognizing Cancer Antigens Generated Rapidly at High Yields
|Frontiers in Immunology|2017|15